Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Janssen’s Imbruvica fails to win NICE backing in lymphoma

But the agency recommends it on the CDF for another type of cancer

Eli Lilly HQ

Lilly gets early US approval for Ibrance rival abemaciclib

The breast cancer treatment, marketed as Verzenio, will also compete with Novartis' Kisqali

- PMLiVE

AbbVie deal with Amgen sets biosimilar Humira launch dates

Agreement will see Europe access the drug over four years earlier than patients in the US

- PMLiVE

Rubius Therapeutics strengthens senior team

Four new hires join the US-based company

- PMLiVE

HRW bolsters global management team

Paul Boyce, Lisa Logan, Yuliya Fontanetti and Katie Olding join the group

Pharma deals continue to slide

But, from payers to the banks to the electorate, who's to blame. Deal Watch investigates

Nektar Therapeutics appoints Jeff Ajer

He joins as an independent director

Brexit implications for UK pharma legislation

What are the potential options and outcomes of the negotiations?

Hunt vs Hawking: We’ll call it a draw

Who won the recent bout between Jeremy Hunt and Stephen Hawking? We'll let you score the cards.

Life Healthcare Communications

Makara Health appoints new associate director Helena Wright

Gina Dootson also takes up senior medical writer position

Sanofi reception

Sanofi, Regeneron claim EU approval for eczema drug Dupixent

Analysts suggest the product could be worth €5bn at peak

- PMLiVE

EMA faces ‘permanent damage’ if forced to go to an unpopular city

Warns eight candidate cities wouldn't retain minimum staff numbers it needs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links